AstraZeneca PLC is 132.4x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($286.27 B vs $2.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PAHC | AZN |
|---|---|---|
| Market cap | $2.16 B | $286.27 B |
| US-listed rank | #2048 | #45 |
| Revenue (latest FY) | $1.30B | - |
| Net income (latest FY) | $48.26M | - |
| Net margin | 3.7% | - |
| P/E (trailing FY) | 44.8 | - |
| SEC filings | 733 | 1,004 |
AstraZeneca PLC is 132.4x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($286.27 B vs $2.16 B).
Full pages: PHIBRO ANIMAL HEALTH CORP and AstraZeneca PLC, or browse the full rankings.